Puma Biotechnology Inc (PBYI) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Puma Biotechnology Inc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.957 Good afternoon. My name is Julian and I'll be your conference call operator today. 00:00:04.957 -- 00:00:08.182 At this time, all participants are in a listen-only mode. 00:00:08.182 -- 00:00:12.167 After the speaker's formal remarks, there will be a question and answer session. 00:00:12.167 -- 00:00:16.853 If you'd like to ask a question during that time, simply press the star key, then the 00:00:16.853 -- 00:00:21.018 number one on your telephone keypad. If you'd like to withdraw your question, please 00:00:21.018 -- 00:00:26.105 press star two. If you should require operator assistance during the conference, 00:00:26.105 -- 00:00:31.115 please press star zero. As a reminder, this call is being recorded. 00:00:31.115 -- 00:00:36.341 I would now like to turn the conference call over to Marianne Ohanesian, Senior Director 00:00:36.341 -- 00:00:38.783 of IR for PUMA Biotechnology. 00:00:38.783 -- 00:00:41.884 Thank you. You may begin. 00:00:42.247 -- 00:00:46.791 Thank you, Julian. Good afternoon and welcome to PUMA's conference call to discuss our 00:00:46.791 -- 00:00:49.274 earnings results for the third quarter of 2025. 00:00:49.274 -- 00:00:50.996 Joining 00:00:50.996 -- 00:00:56.001 me on the call today are Alan Auerbach, Chief Executive Officer, President and Chairman 00:00:56.001 -- 00:00:58.452 of the Board of PUMA Biotechnology, 00:00:58.452 -- 00:01:03.838 Maximo Niguez, Chief Financial Officer, Heather Blaber, Senior Vice President 00:01:03.838 -- 00:01:08.964 of Marketing, and Roger Storms, Senior Vice President of Sales. 00:01:08.964 -- 00:01:13.589 After the close today, PUMA issued a news release detailing earnings results for third 00:01:13.589 -- 00:01:15.711 quarter 2025. That 00:01:15.711 -- 00:01:21.898 news rel...